- Home
- TLSI vs KLTR Comparison
TLSI vs KLTR Comparison
Compare TLSI & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- KLTR
- Stock Information
- Founded
- TLSI 2010
- KLTR 2006
- Country
- TLSI United States
- KLTR United States
- Employees
- TLSI N/A
- KLTR N/A
- Industry
- TLSI Medical Specialities
- KLTR EDP Services
- Sector
- TLSI Health Care
- KLTR Technology
- Exchange
- TLSI Nasdaq
- KLTR Nasdaq
- Market Cap
- TLSI 124.9M
- KLTR 389.2M
- IPO Year
- TLSI N/A
- KLTR 2021
- Fundamental
- Price
- TLSI $4.69
- KLTR $2.15
- Analyst Decision
- TLSI Strong Buy
- KLTR Buy
- Analyst Count
- TLSI 6
- KLTR 2
- Target Price
- TLSI $11.75
- KLTR $2.25
- AVG Volume (30 Days)
- TLSI 36.4K
- KLTR 704.1K
- Earning Date
- TLSI 11-14-2024
- KLTR 02-20-2025
- Dividend Yield
- TLSI N/A
- KLTR N/A
- EPS Growth
- TLSI N/A
- KLTR N/A
- EPS
- TLSI N/A
- KLTR N/A
- Revenue
- TLSI $26,891,000.00
- KLTR $177,586,000.00
- Revenue This Year
- TLSI $60.96
- KLTR $3.34
- Revenue Next Year
- TLSI $53.65
- KLTR $1.88
- P/E Ratio
- TLSI N/A
- KLTR N/A
- Revenue Growth
- TLSI 67.90
- KLTR 1.62
- 52 Week Low
- TLSI $3.50
- KLTR $0.76
- 52 Week High
- TLSI $10.42
- KLTR $2.82
- Technical
- Relative Strength Index (RSI)
- TLSI 51.68
- KLTR 47.46
- Support Level
- TLSI $4.72
- KLTR $1.93
- Resistance Level
- TLSI $5.32
- KLTR $2.82
- Average True Range (ATR)
- TLSI 0.31
- KLTR 0.18
- MACD
- TLSI 0.01
- KLTR -0.05
- Stochastic Oscillator
- TLSI 47.52
- KLTR 24.72
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.